COCRYSTAL PHARMA, INC. (COCP) Return on equity 2020–2021
COCRYSTAL PHARMA, INC. (COCP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-27.0%FY2021 · since FY2020: -37.5% → -27.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2021 | -27.0% | +10.5 pp |
| FY2020 | -37.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice